Omar Ishrak to Retire as CEO of Medtronic
Medtronic Chief Executive Officer Omar Ishrak announced his intention to retire in the beginning of 2Q20. Geoff Martha, currently Executive Vice...
Aug 28, 2019,
Company Updates
Competitive Landscape
Ozop Surgical Enters into License Agreement with Spinal Resources
Ozop Surgical entered into an exclusive license agreement to sell various products from Spinal Resources....
Aug 27, 2019,
WishBone Medical Gains Distribution Rights to OsteoCrete Bone Void Filler
WishBone Medical entered into a private label distribution agreement with Bone Solutions for worldwide rights to sell OsteoCrete® bone void...
Aug 15, 2019,
LimaCorporate Enters Distribution Agreement with G21
LimaCorporate completed an agreement to distribute G21's SpaceFlex Cement Spacer portfolio in the European Economic Area, Switzerland, Australia and New Zealand markets....
Aug 02, 2019,
FDA 510(k) Recap: Spinal Devices and Technologies from 1H19
With the NASS 2019 Annual Meeting approaching, it's an ideal time to revisit spine products that have gained FDA 510(k)...
Jul 25, 2019,
BioPoly Signs Exclusive U.K. Distribution Agreement with Hospital Innovations
BioPoly entered into an exclusive agreement with Hospital Innovations Ltd. to distribute BioPoly® partial resurfacing products throughout the U.K....
Jul 24, 2019,
Conformis Establishes Alliance to Focus on ASC Joint Replacement
Conformis entered into an alliance with Regent Surgical Health to focus on outcomes in outpatient joint replacement in alternative sites of...
Jul 16, 2019,
Kuros Biosciences Signs Distribution Agreement with Surgical Specialties for MagnetOs
Kuros Biosciences entered into an agreement whereby Surgical Specialties will distribute MagnetOs synthetic bone graft in Australia and New Zealand....
Jul 09, 2019,
Ortho Development Enters Australian Market
Ortho Development Corporation established a sales and distribution arm in Australia. Regulatory clearances and first surgeries are expected to occur by...
Jun 25, 2019,
Bioventus, MTF Biologics Partner on Product Development
Bioventus and MTF Biologics will collaborate to develop a next-generation placental tissue product for the treatment of knee osteoarthritis....
Jun 06, 2019,
Loading new posts...
No more posts
